1. Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer cell/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008; 26 (25):4124-30. https://doi.org/10.1200/JCO.2008.16.4558;
2. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haemotopoietic and Lymphoid Tissues. 4th ed. Geneva, Switzerland: World Health Organization; 2008.;
3. Swerdlow SH, Campo E, Peleri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127 (20): 2375-90. https://doi.org/10.1182/blood-2016-01-643569;
4. d'Amore F, Gaulard P, Trümper L, et al. Peripheral T-cell lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26 suppl 26: 108-115. https://doi.org/10.1093/annonc/mdv201;
5. Horwitz SM, Ansell SM, Ai WZ, et al. NCCN Guidelines Insights: T-cell lymphomas. Version 2.2018. J Natl Compr Canc Netw 2018; 16 (2): 123-35. https://doi.org/10.6004/jnccn.2018.0007;